Research Article
ABCD3-I and ABCD2 Scores in a TIA Population with Low Stroke Risk
Table 2
Clinical characteristics in included patients with complete data for analysis of the ABCD2 and ABCD3-I scores and excluded patients,
(%) or
.
| | Patient characteristics | Included () | Excluded () |
| | Demographics | | Age in years, mean (±SD) | 68 (10.9) | 73.4 (10.5) | | Male | 183 (60.0) | 144 (52.9) | | Age in years, | | | | Medical history, (%) | | Former TIA | 44 (14.4) | 57 (21) | | Former ischemic stroke | 38 (12.5) | 49 (18.0) | | Former TIA | 44 (14.4) | 57 (21.0) | | Former myocardial infarction | 33 (10.8) | 34 (12.5) | | Diabetes mellitus | 33 (10.8) | 33 (12.1) | | Hypertension | 140 (45.9) | 171 (62.9)† | | Hypercholesterolemia | 104 (34.1) | 112 (41.2)‡ | | Atrial fibrillation | 29 (9.5) | 50 (18.4) | | Current smoker | 55 (18.0) | 39 (14.3) | | Former smoker | 115 (37.7) | 107 (39.3) | | Modified Rankin score value 0 to1 | 259 (84.9) | 218 (80.1) | | ABCD2 score range | | 0 | 4 (1.3) | 3 (1.1) | | 1 | 5 (1.6) | 10 (3.7) | | 2 | 29 (9.5) | 33 (12.1) | | 3 | 70 (23.0) | 52 (19.1) | | 4 | 97 (31.8) | 80 (29.4) | | 5 | 51 (16.7) | 56 (20.6) | | 6 | 37 (12.1) | 31 (11.4) | | 7 | 12 (3.9) | 7 (2.6) | | Medication | | At baseline | | Any antiplatelet treatment | 113 (37.0) | 120 (44.1) | | Any anticoagulation | 24 (7.9) | 32 (11.8) | | Blood pressure-lowering agent | 140 (45.9) | 171 (62.9) | | Lipid-lowering agent | 104 (34.1) | 112 (41.2) | | At discharge | | Any antiplatelet treatment | 276 (90.5) | 224 (82.4) | | Any anticoagulation | 37 (12.1) | 54 (19.9) | | Blood pressure-lowering agent | 168 (55.1) | 188 (69.1) | | Lipid-lowering agent | 264 (86.6) | 219 (80.5) | | No. of strokes | | <1 week | 3 (1.0) | 2 (0.7) | | <3 months | 10 (3.3) | 9 (3.3) | | <1 year | 16 (5.2) | 15 (5.5) |
|
|
†Using blood pressure-lowering medication. ‡Using lipid-lowering medication. Significant difference between the groups ( ). |
